InvestorsHub Logo
Followers 58
Posts 10223
Boards Moderated 1
Alias Born 09/21/2016

Re: powerwalker post# 395840

Tuesday, 01/03/2023 4:40:13 PM

Tuesday, January 03, 2023 4:40:13 PM

Post# of 466050
https://endpts.com/congressional-inquiry-into-highly-atypical-fda-biogen-ties-ends-with-damning-report-no-repercussions/

Well Done . This publication suggests a clear link between the FDA and any BP firm on the Amyloid Plaque path to CNS disease Nirvana. That path goes straight off a cliff, as AVXL will again demonstrate soon (IMO).

IMO, we are witnessing a herd experience brought about by (soon to be) acknowledged collapse of the FDA-Amyloid Thesis solutions as smart owners run for the hills. Not only is AVXL not on the Amyloid CNS causal path but we are on multinational multiple trial paths w/associated linked-validated regulatory bodies and research organizations. That has been our strategic plan. Yes, this plan has been difficult but we can now witness the benefits.

IMO, when this next AMYLOID shoe drops every CNS Disease shareholder will massively abandon the AMYLOID Causal Thesis fleet. ......AVXL will say..." WELCOME ABOARD".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News